Forensic chemistry

Annual Review of Analytical Chemistry

Volumn 2, Issue , 2009, Pages 297-319

  Bell, Suzanne ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

Latent fingerprints; Mass spectrometry; Metrology; Seized drug analysis; Toxicology

Indexed keywords

ARTICLE; CHEMICAL ANALYSIS; FORENSIC MEDICINE; HUMAN; INSTRUMENTATION; LEGAL ASPECT; MASS SPECTROMETRY; METHODOLOGY; DEVICES; LEGISLATION AND JURISPRUDENCE; PROCEDURES; TRENDS;

CHEMISTRY TECHNIQUES, ANALYTICAL; FORENSIC MEDICINE; HUMANS; MASS SPECTROMETRY;

EID: 70349783424     PISSN: 19361327     EISSN: 19361335     Source Type: Book Series    
DOI: 10.1146/annurev-anchem-060908-155251     Document Type: Article

References (150)

1. Lucas A. 1921. Forensic Chemistry. London: Edward Arnold. 268 pp.
2. UK House of Commons, Sci. Technol. Comm. 2005. Forensic Science on Trial. House of Commons London: Station. Off. Ltd. 98 pp. http://www.publications. parliament.uk/pa/cm200405/cmselect/cmsctech/96/96i.pdf. Last accessed 29 Sep. 2008
3. Federal Rules of Evidence. 2006 (1975). Washington, DC: US Gov. Print. Off. 41 pp. http://www.uscourts.gov/rules/EV.2008.pdf. Last accessed 28 Sep. 2008
4. Hennessy SA, Moane M, McDermott M. 2004. The reactivity of ?-hydroxybutyric acid (GHB) and β-butyrolactone (GBL) in alcoholic solutions. J. Forensic Sci. 49:1220-29
5. LeBeau MA, Montgomery MA, Morris-Kukoski C, Schaff JE, Deakin A, Levine B. 2006. A comprehensive study on the variations in urinary concentrations of endogenous β-hydroxybutyrate (GHB). J. Anal. Toxicol. 30:98-105
6. LeBeau MA, Christenson RH, Levine B, Darwin WD, Huestis M.A. 2002. Intra- and interindividual variations in urinary concentrations of endogenous β-hydroxybutyrate. J. Anal. Toxicol. 26:340-46
7. Ciolino LA, Mesmer M, Satzger S, Machal M, McCauley M, Mohrhaus A.S. 2001. The chemical interconversion of GHB and GBL: forensic issues and implications. J. Forensic Sci. 46:1315-23
8. DeFrancesco JV, Witkowski MR, Ciolino L.A. 2006. GHB free acid. I. Solution formation studies and spectroscopic characterization by (HNMR)-H-1 and FT-IR. J. Forensic Sci. 51:321-29
9. Witkowski MR, Ciolino C, DeFrancesco D. 2006. GHB free acid. II. Isolation and spectroscopic characterization for forensic analysis. J. Forensic Sci. 51:330-39
10. Bell SC, Oldfield O, Shakleya S, Petersen P, Mercer J.W. 2006. Chemical composition and structure of the microcrystals formed between silver(I) and β-hydroxybutyric acid and β-hydroxyvaleric acid. J. Forensic Sci. 51:808-11
11. Elie MP, Baron MG, Birkett J.W. 2008. Enhancement of microcrystalline identification of β-hydroxybutyrate. J. Forensic Sci. 53:147-50
12. Chappell JS, Meyn AW, Ngim K.K. 2004. The extraction and infrared identification of β-hydroxybutyric acid (GHB) from aqueous solutions. J. Forensic Sci. 49:52-59
13. LeBeau MA, Montgomery MA, Miller ML, Burmeister S.G. 2000. Analysis of biofluids for β-hydroxybutyrate (GHB) and β-butyrolactone (GBL)by headspace GC-FID and GC-MS. J. Anal. Toxicol. 24:421-28
14. LeBeau MA, Montgomery MA, Morris-Kukoski C, Schaff JE, Deakin A. 2007. Further evidence of in vitro production of β-hydroxybutyrate (GHB) in urine samples. Forensic Sci. Int. 169:152-56
15. Kalasinsky KS, Dixon D, Schmunk S, Kish S.J. 2001. Blood, brain, and hair GHB concentrations following fatal ingestion. J. Forensic Sci. 46:728-30
16. Verschraagen M, Maes A, Ruiter B, Bosman IJ, Smink BE, Lusthof K.J. 2007. Post-mortem cases involving amphetamine-based drugsinthe Netherlands: comparison with driving under the influence cases. Forensic Sci. Int. 170:163-70
17. Blair S, Song M, Hall B, Brodbelt J. 2001. Determination of β-hydroxybutyrate in water and human urine by solid phase microextraction-gas chromatography/quadrupole ion trap spectrometry. J. Forensic Sci. 46:688-93
18. Brown SD, Rhodes DJ, Pritchard B.J. 2007. A validated SPME-GC-MS method for simultaneous quantification of club drugs in human urine. Forensic Sci. Int. 171:142-50
19. Frison G, Tedeschi L, Maietti S, Ferrara S.D. 2000. Determination of β-hydroxybutyric acid (GHB) in plasma and urine by headspace solid-phase microextraction and gas chromatography/positive ion chemical ionization mass spectrometry. Rapid Commun. Mass Spectrom. 14:2401-7
20. Meyers JE, Almirall J.R. 2005. Analysis of β-hydroxybutyric acid (GHB) in spiked water and beverage samples using solid phase microextraction (SPME) on fiber derivatization/gas chromatography-mass spectrometry (GC/MS). J. Forensic Sci. 50:31-36
21. Harrington PD, Rauch PJ, Cai C.S. 2001. Multivariate curve resolution of wavelet and Fourier compressed spectra. Anal. Chem. 73:3247-56
22. Mercer J, Shakleya D, Bell S. 2006. Applications of ion mobility spectrometry (IMS) to the analysis of β-hydroxybutyrate and β-hydroxyvalerate in toxicological matrices. J. Anal. Toxicol. 30:539-44
23. Patchett ML, Minoshima Y, Harrington P.B. 2002. Detection of β-hydroxybutyrate and β-butyrolactone by ion mobility spectrometry. Spectroscopy 17:16-24
24. Bortolotti F, De Paoli G, Gottardo R, Trattene M, Tagliaro F. 2004. Determination of β-hydroxybutyric acid in biological fluids by using capillary electrophoresis with indirect detection. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 800:239-44
25. Lurie IS, Hays PA, Parker K. 2004. Capillary electrophoresis analysis of a wide variety of seized drugs using the same capillary with dynamic coatings. Electrophoresis 25:1580-91
26. Wood M, Laloup M, Samyn S, Morris M, de Bruijn EA, et al. 2004. Simultaneous analysis of β-hydroxybutyric acid and its precursors in urine using liquid chromatography-tandem mass spectrom-etry. J. Chromatogr. A 1056:83-90
27. Zacharis CK, Raikos N, Giouvalakis G, Tsoukali-Papadopoulou H, Theodoridis GA. 2008. A new method for the HPLC determination of β-hydroxybutyric acid (GHB) following derivatization with a coumarin analogue and fluorescence detection-application in the analysis of biological fluids. Talanta 75:356-61
28. Kaufmann E, Alt A. 2007. Determination ofGHB inurine and serum byLC/MS usingasimple one-step derivative. Forensic Sci. Int. 168:133-37
29. SWGDRUG, US Dep. Justice, Drug Enforc. Adm. 2007. Scientific Working Group for the Analysis of Seized Drugs (SWGDRUG) Recommendations, 3rd ed., 54 pp. http://www.swgdrug.org/Documents/SWGDRUG%20Recommendations.pdf. Last accessed 29 Sep. 2008
30. Izenman A.J. 2001. Statistical and legal aspects of the forensic study of illicit drugs. Stat. Sci. 16:35-57
31. Izenman A.J. 2003. Sentencing illicit drug traffickers: How do the courts handle random sampling issues? Int. Stat. Rev. 71:535-56
32. Drugs Work. Group, Eur. Netw. Forensic Sci. Inst. (ENFSI). 2003. Guidelines on Representative Drug Sampling. The Hague: ENFSI. http://www.enfsi.eu. Last accessed 29 Sep. 2008
33. Balon K, Riebesehl BU, Muller B.W. 1999. Determination of liposome partitioning of ionizable drugs by partitioning. J. Pharm. Sci. 88:802-6
34. Rustichelli C, Ferioli V, Vezzalini F, Gamberini G. 1996. Simultaneous separation and identification of hashish constituents by coupled liquid chromatography mass spectrometry (HPLC-MS). Chromatographia 43:129-34
35. Webb KS, Baker B, Cassells C, Francis F, Johnston J, et al. 1996. The analysis of lysergide (LSD): the development of novel enzyme immunoassay and immunoaffinity extraction procedures together with an HPLC-MS confirmation procedure. J. Forensic Sci. 41:938-46
36. Ng LK, Lafontaine P, Brazeau L. 2002. Ballpoint pen inks: characterization by positive and negative ion-electrospray ionization mass spectrometry for the forensic examination of writing inks. J. Forensic Sci. 47:1238-47
37. Sakayanagi M, Komuro J, Konda Y, Watanabe K, Harigaya Y. 1999. Analysis of ballpoint pen inks by field desorption mass spectrometry. J. Forensic Sci. 44:1204-14
38. Bogusz M.J. 2000. Liquid chromatography-mass spectrometry as a routine method in forensic sciences: a proof of maturity. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 748:3-19
39. Gergov M, Robson JN, Ojanpera I, Heinonen OP, Vuori E. 2001. Simultaneous screening and quanti-tation of 18 antihistamine drugs in blood by liquid chromatography ionspray tandem mass spectrometry. Forensic Sci. Int. 121:108-15
40. Marquet P. 2002. Progress of liquid chromatography-mass spectrometry in clinical and forensic toxicology. Ther. Drug Monit. 24:255-76
41. Laza D, Nys B, De Kinder J, Mesmaeker AKD, Moucheron C. 2007. Development of a quantitative LC-MS/MS method for the analysis of common propellant powder stabilizers in gunshot residue. J. Forensic Sci. 52:842-50
42. Ostin A, Bergstrom T, Fredriksson SA, Nilsson C. 2007. Solvent-assisted trypsin digestion of ricin for forensic identification by LC-ESI MS/MS. Anal. Chem. 79:6271-78
43. Dresen S, Weinmann W, Wurst F.M. 2004. Forensic confirmatory analysisofethyl sulfate-a new marker for alcohol consumption-by liquid-chromatography/electrospray ionization/tandem mass spectrome-try. J. Am. Soc. Mass Spectrom. 15:1644-48
44. Weinmann W, Schaefer P, Thierauf A, Schreiber A, Wurst F.M. 2004. Confirmatory analysis of ethylglucuronide in urine by liquid-chromatography/ electrospray ionization/tandem mass spectrometry according to forensic guidelines. J. Am. Soc. Mass Spectrom. 15:188-93 (Pubitemid 38183207)
45. Mueller CA, Weinmann W, Dresen S, Schreiber A, Gergov M. 2005. Development of a multi-target screening analysis for 301 drugs using a QTrap liquid chromatography/tandem mass spectrometry system and automated library searching. Rapid Commun. Mass Spectrom. 19:1332-38
46. Bicker W, Lammerhofer M, Keller T, Schuhmacher R, Krska R, Lindner W. 2006. Validated method for the determination of the ethanol consumption markers ethyl glucuronide, ethyl phosphate, and ethyl sulfate in human urine by reversed-phase/weak anion exchange liquid chromatography-tandem mass spectrometry. Anal. Chem. 78:5884-92
47. Pizzolato TM, de Alda MJL, Barcelo D. 2007. LC-based analysis of drugs of abuse and their metabolites in urine. Trends Anal. Chem. 26:609-24
48. You YW, Uboh U, Soma S, Guan G, Li L, et al. 2007. Biomarkers of alcohol abuse in racehorses by liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom. 21:3785-94
49. Andersson M, Gustavsson E, Stephanson N, Beck O. 2008. Direct injection LC-MS/MS method for identification and quantification of amphetamine, methamphetamine, 3, 4-methylenedioxyamphetamine and 3, 4- methylenedioxymethamphetamine in urine drug testing. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 861:22-28
50. Ackerman BL, Berna B, Eckstein E, Ott O, Chaudhary A.K. 2008. Current applications of liquid chromatography/mass spectrometry in pharmaceutical discovery after a decade of innovation. Annu. Rev. Anal. Chem. 1:357-96
51. Gheorghe A, Van Nuijs A, Pecceu B, Bervoets B, Jorens J, et al. 2008. Analysis of cocaine and its principal metabolites in waste and surface water using solid-phase extraction and liquid chromatography- ion trap tandem mass spectrometry. Anal. Bioanal. Chem. 391:1309-19
52. Lajeunesse A, Gagnon C, Sauve S. 2008. Determination of basic antidepressants and their n-desmethyl metabolites in raw sewage and wastewater using solid-phase extraction and liquid chromatography- tandem mass spectrometry. Anal. Chem. 80:5325-33
53. Verenitch SS, Mazumder A. 2008. Development of a methodology utilizing gas chromatography ion-trap tandem mass spectrometry for the determination of low levels of caffeine in surface marine and freshwater samples. Anal. Bioanal. Chem. 391:2635-46
54. Gergov M, Boucher B, Ojanpera I, Vuori E. 2001. Toxicological screening of urine for drugs by liquid chromatography/time-of-flight mass spectrometry with automated target library search based on elemental formulas. Rapid Commun. Mass Spectrom. 15:521-26
55. Pelander A, Ojanpera I, Laks S, Rasanen I, Vuori E. 2003. Toxicological screening with formula-based metabolite identification by liquid chromatography/time-of-flight mass spectrometry. Anal. Chem. 75:5710-18
56. Laks S, Pelander A, Vuori V, Ali-Tolppa E, Sippola E, Ojanpera I. 2004. Analysis of street drugs in seized material without primary reference standards. Anal. Chem. 76:7375-79
57. Ojanpera I, Pelander A, Laks S, Gergov M, Vuori E, Witt M. 2005. Application of accurate mass measurement to urine drug screening. J. Anal. Toxicol. 29:34-40 (Pubitemid 40128943)
58. Kolmonen M, Leinonen A, Pelander A, Ojanpera I. 2007. A general screening method for doping agents in human urine by solid phase extraction and liquid chromatography/time-of-flight mass spectrometry. Anal. Chim. Acta 585:94-102
59. Cotte-Rodriguez I, Mulligan CC, Cooks R.G. 2007. Non-proximate detection of small and large molecules by desorption electrospray ionization and desorption atmospheric pressure chemical ion-ization mass spectrometry: instrumentation and applications in forensics, chemistry, and biology. Anal. Chem. 79:7069-77
60. Ratcliffe LV, Rutten R, Barrett B, Whitmore T, Seymour D, et al. 2007. Surface analysis under ambient conditions using plasma-assisted desorption/ionization mass spectrometry. Anal. Chem. 79:6094-101
61. Takats Z, Wiseman JM, Cooks R.G. 2005. Ambient mass spectrometry using desorption electrospray ionization (DESI): instrumentation, mechanisms and applications in forensics, chemistry, and biology. J. Mass Spectrom. 40:1261-75
62. Zhao MX, Zhang Z, Yang Y, Xu X, Wen W, et al. 2008. Desorption electrospray tandem MS (DESI-MSMS) analysis of methyl centralite and ethyl centralite as gunshot residues on skin and other surfaces. J. Forensic Sci. 53:807-11
63. Ebejer KA, Brereton B, Carter C, Ollerton O, Sleeman R. 2005. Rapid comparison of diacetylmor-phine on banknotes by tandem mass spectrometry. Rapid Commun. Mass Spectrom. 19:2137-43
64. Casale J, Casale E, Collins M, Morello D, Cathapermal S, Panicker S. 2006. Stable isotope analyses of heroin seized from the merchant vessel Pong Su. J. Forensic Sci. 51:603-6 (Pubitemid 43748624)
65. Casale JF, Ehleringer E, Morello M, Lott M.J. 2005. Isotopic fractionation of carbon and nitrogen during the illicit processing of cocaine and heroin in South America. J. Forensic Sci. 50:1315-21
66. Idoine FA, Carter JF, Sleeman R. 2005. Bulk and compound-specific isotopic characterisation of illicit heroin and cling film. Rapid Commun. Mass Spectrom. 19:3207-15
67. Buttigieg GA, Baker ME, Ruiz J, Denton M.B. 2003. Lead isotope ratio determination for the forensic analysis of military small arms projectiles. Anal. Chem. 75:5022-29
68. Pierrini G, Doyle S, Champod C, Taroni F, Wakelin D, Lock C. 2007. Evaluation of preliminary isotopic analysis (C-13 and N-15) of explosives: a likelihood ratio approach to assess the links between semtex samples. Forensic Sci. Int. 167:43-48
69. Carter JF, Grundy G, Hill H, Ronan R, Titterton T, Sleeman R. 2004. Forensic isotope ratio mass spectrometry of packaging tapes. Analyst 129:1206-10
70. Benson S, Lennard C, Maynard P, Roux C. 2006. Forensic applications of isotope ratio mass spectrometry-a review. Forensic Sci. Int. 157:1-22
71. Galimov EM, Sevastyanov S, Kulbachevskaya K, Golyavin A.A. 2005. Isotope ratio mass spectrometry: δ13 C and δ15 N analysis for tracing the origin of illicit drugs. Rapid Commun. Mass Spectrom. 19:1213-16
72. Saudan C, Augsburger M, Mangin P, Saugy M. 2007. Carbon isotopic ratio analysis by gas chromatog-raphy/combustion/isotope ratio mass spectrometry for the detection of γ-hydroxybutyric acid (GHB) administration to humans. Rapid Commun. Mass Spectrom. 21:3956-62
73. Aguilera R, Chapman TE, Starcevic B, Hatton CK, Catlin D.H. 2001. Performance characteristics of a carbon isotope ratio method for detecting doping with testosterone based on urine diols: controls and athletes with elevated testosterone/epitestosterone ratios. Clin. Chem. 47:292-300
74. Baume N, Saudan C, Desmarchelier A, Strahm E, Sottas PE, et al. 2006. Use of isotope ratio mass spectrometry to detect doping with oral testosterone undecanoate: inter-individual variability of C-13/C-12 ratio. Steroids 71:364-70
75. Cawley AT, Hine H, Trout T, George G, Kazlauskas R. 2004. Searching for new markers of endogenous steroid administration in athletes: "looking outside the metabolic box". Forensic Sci. Int. 143:103-14
76. Flenker U, Guntner U, Schan̈zer W. 2008. γ13 C values of endogenous urinary steroids. Steroids 73:408-16
77. Piper T, Mareck U, Geyer H, Flenker U, Thevis M, et al. 2008. Determination of 13C/12C ratios of endogenous urinary steroids: method validation, reference population and application to doping control purposes. Rapid Commun. Mass Spectrom. 22:2161-75
78. Saudan C, Baume N, Mangin P, Saugy M. 2004. Urinary analysis of 16(5 α)-androsten-3 α-ol by gas chromatography/combustion/isotope ratio mass spectrometry: implications in antidoping analysis. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 810:157-64 (Pubitemid 39195036)
79. Saudan C, Baume N, Robinson N, Avois L, Mangin P, Saugy M. 2006. Testosterone and doping control. Br. J. Sports Med. 40:21-24
80. Sottas PE, Baume N, Saudan S, Schweizer C, Kamber M, Saugy M. 2007. Bayesian detection ofabnormal values in longitudinal biomarkers with an application to T/E ratio. Biostatistics 8:285-96
81. Sottas PE, Saudan C, Schweizer C, Baume N, Mangin P, Saugy M. 2008. From population- to subject-based limits of T/E ratio to detect testosterone abuse in elite sports. Forensic Sci. Int. 174:166-72
82. Hansen DB, Joullie M.M. 2005. The development of novel ninhydrin analogues. Chem. Soc. Rev. 34:408-17
83. Hark RR, Hauze DB, Petrovskaia O, Joullie M.M. 2001. Synthetic studies of novel ninhydrin analogs. Can. J. Chem. Rev. Can. Chim. 79:1632-54
84. Lin SS, Yemelyanov Y, Pugh P, Engheta N. 2006. Polarization-based and specular-reflection-based noncontact latent fingerprint imaging and lifting. J. Opt. Soc. Am. A: Opt. Image Sci. Vis. 23:2137-53
85. Petraco NDK, Proni G, Jackiw JJ, Sapse A.M. 2006. Amino acid alanine reactivity with the fingerprint reagent ninhydrin. A detailed ab initio computational study. J. Forensic Sci. 51:1267-75
86. Sapse D, Petraco P. 2007. A step on the path in the discovery of new latent fingerprint development reagents: substituted Ruhemann's purples and implications for the law. J. Mol. Model. 13:943-48
87. Schwarz L, Nat P, Frerichs I. 2002. Advanced solvent-free application of ninhydrin for detection of latent fingerprints on thermal paper and other surfaces. J. Forensic Sci. 47:1274-77
88. Ramminger U, Nickel U, Geide B. 2001. Enhancement of an insufficient dye-formation in the ninhydrin reaction by a suitable post treatment process. J. Forensic Sci. 46:288-93
89. Wilkinson D. 2000. Study of the reaction mechanism of 1, 8-diazafluoren-9-one with the amino acid, l-alanine. Forensic Sci. Int. 109:87-103
90. Conn C, Ramsay G, Roux C, Lennard C. 2001. The effect of metal salt treatment on the photoluminescence of DFO-treated fingerprints. Forensic Sci. Int. 116:117-23
91. Roux C, Jones N, Lennard C, Stoilovic M. 2000. Evaluation of 1, 2-indanedione and 5, 8-dimethoxy-1, 2-indanedione for the detection of latent fingerprints on porous surfaces. J. Forensic Sci. 45:761-69
92. Wallace-Kunkel C, Lennard C, Stoilovic M, Roux C. 2007. Optimisation and evaluation of 1, 2-indanedione for use as a fingermark reagent and its application to real samples. Forensic Sci. Int. 168:14-26
93. Alaoui IM, Menzel ER, Farag M, Cheng KH, Murdock R.H. 2005. Mass spectra and time-resolved fluorescence spectroscopy of the reaction product of glycine with 1, 2-indanedione in methanol. Forensic Sci. Int. 152:215-19
94. Almog J, Levinton-Shamuilov G, Cohen Y, Azoury M. 2007. Fingerprint reagents with dual action: color and fluorescence. J. Forensic Sci. 52:330-34
95. Almog J, Stepanov N, Dubnikova F. 2008. Protection of the carbonyl groups in 1, 2-indanedione: propellane versus acetal formation. Tetrahedron Lett. 49:1870-76
96. Takatsu M, Shimoda O, Onishi K, Onishi A, Oguri N. 2008. Detection of pretreated fingerprint fluorescence using an LED-based excitation system. J. Forensic Sci. 53:823-27
97. Murphy C.J. 2002. Optical sensing with quantum dots. Anal. Chem. 74:520-26A
98. Murphy CJ, Coffer J.L. 2002. Quantum dots: a primer. Appl. Spectrosc. 56:16-27A
99. Sametband M, Shweky I, Banin U, Mandler D, Almog J. 2007. Application of nanoparticles for the enhancement of latent fingerprints. Chem. Commun. (Camb.) 1142-44
100. Menzel ER, Savoy S, Ulvick U, Cheng C, Murdock M, Sudduth M.R. 2000. Photoluminescent semiconductor nanocrystals for fingerprint detection. J. Forensic Sci. 45:545-51
101. Menzel ER, Takatsu M, Murdock RH, Bouldin K, Cheng K.H. 2000. Photoluminescent CdS/dendrimer nanocomposites for fingerprint detection. J. Forensic Sci. 45:770-73
102. Yu-Juan J, Yun-Jun L, Guo-Ping L, Jie L, Yuan-Feng W, et al. 2008. Application of photoluminescent CdS/PAMAM nanocomposites in fingerprint detection. Forensic Sci. Int. 179:34-38
103. Liu L, Gill G, Gao G, Hope-Weeks LJ, Cheng K.H. 2008. Exploration of the use of novel SiO2 nanocomposites doped with fluorescent Eu3+/sensitizer complex for latent fingerprint detection. Forensic. Sci. Int. 176:163-72
104. Wargacki SP, Lewis LA, Dadmun M.D. 2007. Understanding the chemistry of the development of latent fingerprints by superglue fuming. J. Forensic Sci. 52:1057-62
105. Edwards HGM, Day J.S. 2006. Anomalies in polycyanoacrylate formation studied by Raman spec-troscopy: implications for the forensic enhancement of latent fingerprints for spectral analysis. Vib. Spectrosc. 41:155-59
106. Day JS, Edwards E, Dobrowski D, Voice A.M. 2004. The detection of drugs of abuse in fingerprints using Raman spectroscopy. II. Cyanoacrylate-fumed fingerprints. Spectrochim. Acta A Mol. Biomol. Spectrosc. 60:1725-30
107. Day JS, Edwards E, Dobrowski D, Voice A.M. 2004. The detectionofdrugs of abuse in fingerprints using Raman spectroscopy. I. Latent fingerprints. Spectrochim. Acta A Mol. Biomol. Spectrosc. 60:563-68
108. West MJ, Went M.J. 2008. The spectroscopic detection of exogenous material in fingerprints after development with powders and recovery with adhesive lifters. Forensic Sci. Int. 174:1-5
109. Crane NJ, Bartick B, Perlman P, Huffman S. 2007. Infrared spectroscopic imaging for noninvasive detection of latent fingerprints. J. Forensic Sci. 52:48-53
110. Miskelly GA, Wagner J.H. 2005. Using spectral information in forensic imaging. Forensic Sci. Int. 155:112-18
111. Ricci C, Phiriyavityopas P, Curum C, Chan C, Jickells S, Kazarian S.G. 2007. Chemical imaging of latent fingerprint residues. Appl. Spectrosc. 61:514-22
112. Williams DK, Schwartz RL, Bartick E.G. 2004. Analysis of latent fingerprint deposits by infrared mi-crospectroscopy. Appl. Spectrosc. 58:313-16
113. Payne G, Roux C, Lennard C, Comber B, Exline D. 2003. Applications of chemical imaging to the detection of latent fingerprints. Forensic Sci. Int. 136:131
114. Tahtouh M, Despland P, Shimmon S, Kalman K, Reedy B.J. 2007. The application of infrared chemical imaging to the detection and enhancement of latent fingerprints: method optimization and further findings. J. Forensic Sci. 52:1089-96
115. Zhang MQ, Girault H.H. 2007. Fingerprint imaging by scanning electrochemical microscopy. Elec-trochem. Commun. 9:1778-82
116. Worley CG, Wiltshire W, Miller M, Havrilla H, Majidi V. 2006. Detection of visible and latent fingerprints using micro-X-ray fluorescence elemental imaging. J. Forensic Sci. 51:57-63
117. Worley CG, Wiltshire W, Miller M, Havrilla H, Majidi V. 2006. Detection of visible and latent fingerprints by micro-X-ray fluorescence. Powder Diffr. 21:136-39
118. Ifa DR, Manicke M, Dill D, Cooks R.G. 2008. Latent fingerprint chemical imaging by mass spec-trometry. Science 321:805
119. Saks MJ, Risinger DM, Rosenthal R, Thompson W.C. 2003. Context effects in forensic science: a review and application of the science of science to crime laboratory practice in the United States. Sci. Justice 43:77-90
120. Jones A.W. 2007. The distribution of forensic journals, reflections on authorship practices, peer-review and role of the impact factor. Forensic Sci. Int. 165:115-28
121. Brettell TA, Inman K, Rudin N, Saferstein R. 2001. Forensic science. Anal. Chem. 73:2735-44
122. Brettell TA, Rudin N, Saferstein R. 2003. Forensic science. Anal. Chem. 75:2877-90
123. Brettell TA, Butler JM, Saferstein R. 2005. Forensic science. Anal. Chem. 77:3839-60
124. Brettell TA, Butler JM, Almirall J.R. 2007. Forensic science. Anal. Chem. 79:4365-84
125. Smith ML, Vorce V, Holler H, Shimomura E, Magluilo J, et al. 2007. Modern instrumental methods in forensic toxicology. J. Anal. Toxicol. 31:237-53
126. Rendle D.F. 2005. Advances in chemistry applied to forensic science. Chem. Soc. Rev. 34:1021-31
127. Peters FT, Maurer H.H. 2002. Bioanalytical method validation and its implications for forensic and clinical toxicology-a review. Accredit. Qual. Assur. 7:441-49
128. Cuadros-Rodriguez L, Romero R, Bosque-Sendra JM. 2005. The role of the robustness/ruggedness and inertia studies in research and development of analytical processes. Crit. Rev. Anal. Chem. 35:57-69
129. Konieczka P. 2007. The role of and the place of method validation in the quality assurance and quality control (QA/QC) system. Crit. Rev. Anal. Chem. 37:173-90
130. Hartmann C, Smeyers-Verbeke J, Massart DL, McDowall RD. 1998. Validation of bioanalytical chro-matographic methods. J. Pharm. Biomed. Anal. 17:193-218
131. Peters FT, Drummer OH, Musshoff F. 2007. Validation of new methods. Forensic Sci. Int. 165:216-24
132. Lee S, Park Y, Han E, Choe S, Lim M, Chung H. 2008. Preparation and application of a fortified hair reference material for the determination of methamphetamine and amphetamine. Forensic Sci. Int. 178:207-12
133. Samyn N, Laloup M, De Boeck G. 2007. Bioanalytical procedures for determination of drugs of abuse in oral fluid. Anal. Bioanal. Chem. 388:1437-53
134. Pragst F. 2007. Application of solid-phase microextraction in analytical toxicology. Anal. Bioanal. Chem. 388:1393-414
135. Drummer O.H. 2007. Requirements for bioanalytical proceduresinpostmortem toxicology. Anal. Bioanal. Chem. 388:1495-503
136. Furton KG, Wang J, Hsu YL, Walton J, Almirall J.R. 2000. The use of solid-phase microextraction-gas chromatography in forensic analysis. J. Chromatogr. Sci. 38:297-306
137. Anastos N, Barnett NW, Lewis S.W. 2005. Capillary electrophoresis for forensic drug analysis: a review. Talanta 67:269-79
138. Srogi K. 2006. Hair analysis-a tool in biomedical, environmental and forensic sciences: a review of literature published after 1989. Chem. Anal. 51:3-34
139. Cruces-Blanco C, Gamiz-Gracia L, Garcia-Campana AM. 2007. Applications ofcapillary electrophoresis in forensic analytical chemistry. Trends Anal. Chem. 26:215-26
140. Negrusz A, Gaensslen R.E. 2003. Analytical developments in toxicological investigation of drug-facilitated sexual assault. Anal. Bioanal. Chem. 376:1192-97
141. Pert AD, Baron MG, Birkett J.W. 2006. Review of analytical techniques for arson residues. J. Forensic Sci. 51:1033-49
142. Romolo FS, Margot P. 2001. Identificationof gunshot residue: a critical review. Forensic Sci. Int. 119:195-211
143. Verpoorte E. 2002. Microfluidic chips for clinical and forensic analysis. Electrophoresis 23:677-712
144. Horsman KM, Bienvenue B, Blasier B, Landers J.P. 2007. Forensic DNA analysis on microfluidic devices: a review. J. Forensic Sci. 52:784-99
145. UN Off. Drugs Crime (UNODC). 1998. Recommended Methods for Testing Opium, Morphine, and Heroin. UN Doc. No. ST/NAR/29/Rev.1, 82 pp. Vienna: UNODC. http://www.unodc.org/pdf/publications/st-nar-29-rev1.pdf. Last accessed 29 Sep. 2008
146. Colon M, Rodriguez G, Diaz R.O. 1993. Representative sampling of street drug exhibits. J. Forensic Sci. 38:641-48
147. Aitken C.G.G. 1999. Sampling-how big a sample? J. Forensic Sci. 44:750-60
148. Aitken CGG, Lucy D. 2002. Estimation of the quantity of a drug in a consignment from measurements on a sample. J. Forensic Sci. 47:968-75
149. Frank RS, Hinkley SW, Hoffman C.G. 1991. Representative sampling of drug seizures in multiple containers. J. Forensic Sci. 36:350-57
150. ASTM Int. 2000. Standard Practices for Calculating Sample Size to Estimate, with a Specified Tolerable Error, the Average for Characteristics of a Lot or Process. West Conshohocken, PA: ASTM Int. http://www.astm.org/Standards/ E122.htm. Last accessed 29 Sep. 2008